CASI Pharma Stock Price (NASDAQ:CASI)

Add to My Stocks
$3.84 $0.01 (0.26%) CASI stock closing price Feb 16, 2018 (Closing)
Prev Close* : $3.85
Market Cap:
Day Low: $3.67
52 Week Low: $0.91
Open: $3.82
Volume: -
Day High: $3.92
52 Week High: $4.84

Latest Stock Market News

Latest Articles

CASI Stockcharts

View CASI PE ratio, PS ratio stocks charts and compare with peers.
CASI Chart
Note: Compare CASI Pharma stock price history with the index and industry peers.

CASI Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

CASI Pharma Returns

(return on equity)

CASI Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

CASI Industry Peers

Company Price Change (%)
Calithera Biosciences (CALA)8.11.15 (16.55%)
Ampio Pharma (AMPE)2.960.5 (14.45%)
Amgen (AMGN)183.550.05 (0.03%)
Molecular Templ (MTEM)8.860.37 (4.01%)
Tetralogic Pharma (TLOG)0.030 (0%)
Neurocrine Biosciences (NBIX)85.250.32 (0.37%)
Repligen (RGEN)32.750.11 (0.33%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Galectin Therapeutics (GALT)4.340.34 (8.5%)
ImmunoGen (IMGN)11.270.62 (5.82%)
ArQule (ARQL)1.720.09 (5.52%)
Nature's Sunshine Products (NATR)11.950.5 (4.37%)
Depomed (DEPO)7.440.28 (3.91%)
MediWound (MDWD)4.350.15 (3.57%)
Redhill Biopharma (RDHL)6.120.19 (3.2%)
Top gainers from Medical-Drugs industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Pacira Pharma (PCRX)30.155.95 (16.48%)
Flexion Therapeutics (FLXN)23.191.39 (5.66%)
Recro Pharma (REPH)8.30.4 (4.6%)
Arrowhead Pharma (ARWR)5.570.26 (4.46%)
Akebia Therapeutics (AKBA)14.140.64 (4.33%)
MOLECULAR TEMPL (MTEM)8.860.37 (4.01%)
Synergy Pharma (SGYP)2.030.08 (3.79%)
Top losers from Medical-Drugs industry
* As of Feb 17, 2018

CASI Pharmaceuticals Inc Stock News - Partner Headlines

CASI Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-9.45M-7.2M-26.2M-5.73M-14.54M
Total Operating Expense9.41M7.18M26.19M5.73M5.16M
View CASI Pharma income statement
balance sheet20162015201420132012
Total Assets27.71M5.82M11.3M15.5M8.97M
Total Liabilities6.92M11.91M11.73M--
Shareholders Equity20.78M-6.08M-0.42M14.94M8.23M
View CASI Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities----1.29M
Net Cash from (used by) Operating Activities-6.02M-5.51M-3.99M-3.27M-2.21M
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.02M-0.23M-0.04M-0.04M
View CASI Pharma cash flow statement

CASI Pharma Stock Message Board

An investor needs to spend $3.84 to buy CASI stock, as the closing CASI Pharma stock price is $3.84. Stock price or share price can be used to find the total market value of a company. CASI Pharma market cap stands at $268.43M as of Feb 16, 2018. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing CASI Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that CASI Pharma is worth a lot, it will most likely be reflected in an inflated CASI Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 93,298 shares were traded with a closing stock price of $3.84 as of Feb 16, 2018, as can be seen from CASI Pharma stock quote. One can view CASI Pharma stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. CASI Pharma dividend per share was 0.00 during the last quarter. CASI Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.